ページ4 - 最高の膀胱癌医師 - トップ117名の医師

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

医師は30年以上の経験を持つ免疫学者であり、免疫学の最先端分野であるウイルス療法を専門としています。 <\/p>

リガ医科大学を卒業し、内科でのインターンシップを修了しました。 <\/p>

現在、Pauls Stradins Clinical University Hospitalの臨床免疫学センターの責任者を務めています。<\/p>

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Mohamed Mahmoud Abdelhakim is Head of Radiation Oncology at Shefa al Orman Hospital, Luxor. He is Professor of Radiation Oncology at the National Cancer Institute, Cairo University. He previously served as Associate Professor (2015–2020), Lecturer (2010–2015), Assistant Lecturer (2003–2009), and Resident (2000–2003). He also worked as a Specialist at Gharbia Cancer Society.

He treats inpatients and outpatients with breast, soft tissue sarcoma, lymphoma, gynecologic, gastrointestinal, genitourinary, and CNS tumors. His skills include image-guided brachytherapy, IMRT, VMAT, SRS, and SBRT. He performs conventional and CT-based planning and 3D-CRT. He works with cobalt and linear accelerators and electron beam therapy. He provides HDR and LDR intracavitary and interstitial brachytherapy. He also performs stereotactic radiotherapy, total body irradiation, and total skin irradiation.

Member: Egyptian Cancer Society, ESTRO, ESMO.

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Urologist, Surgeon

モントルシ教授は、イタリアの泌尿器学およびアンドロロジーのトップ専門家の一人です。 数多くの科学的賞を持っています。 イタリアの泌尿器研究所（URI）を指導しており、過去10年間で最も影響力のある研究者の一人として認識されています。

専門

モントルシ教授は、低侵襲手術およびロボット技術を用いて膀胱、前立腺、腎臓のがん治療を提供しています。

8,000以上の泌尿器科およびアンドロロジーの手術を提供してきました。

閉塞性静脈機能障害を修正するための静脈パッチ法を開発しました。

職務経験

• 2013年以来 — サン・ラファエール科学研究所の科学ディレクター（イタリア）
• ミラノのヴィータサルーテサン・ラファエーレ大学泌尿器科部門の泌尿器研究所（URI）のディレクター

教育

• 1987 — ミラノ大学医学部 — 医学および外科学の学位
• 1992 — ミラノ大学医学部 — 泌尿器科学の専門
• 2017 — イングランド王立外科医師会 — 名誉会員。

受賞歴

• 1998 — クリスタル・マトゥラ賞、ヨーロッパ泌尿器学会より40歳未満の最優秀欧州泌尿器科医として
• 2016 — イタリア共和国功労勲章司令官
• 2018 — アメリカ泌尿器学会のヒュー・ハンプトン・ヤング賞、泌尿器科学院と泌尿器腫瘍学への優れた貢献で（モントルシ博士はこの賞を受けた最初の非アメリカ人です）
• 2019 — フランス・ドブルーン生涯業績賞、ヨーロッパ泌尿器学会より、学会発展への優れた貢献で。

科学活動

モントルシ教授は1,000以上の論文を執筆しています。

ウェブサイエンスグループは、過去10年間で最も影響力のある研究者のリストに医師を含めました。

教育活動

• 2012年以来 — 泌尿器科医学校ディレクター — ヴィータサルーテサン・ラファエーレ大学（イタリア）
• 2008-2012 — 泌尿器科教授 — ヴィータサルーテサン・ラファエーレ大学（イタリア）
• 2002-2008 — 泌尿器科准教授 — ヴィータサルーテサン・ラファエーレ大学（イタリア）。

組織への所属

• ヨーロッパ学術泌尿器科学会（AAEU）
• アメリカ生殖泌尿器外科学会
• アメリカ泌尿器科学会
• エンドウロロジー学会
• ヨーロッパ泌尿器科学会
• ヨーロッパ性医学会（ESSM）
• イタリアアンドロロジー学会（SIA）
• イタリア泌尿器科学会。

Oncosurgeon, Head of Samsung Department of Urology

この医師は、イスタンブールのMedical Park Gaziosmanpaşa Hospitalで著名な泌尿器科医であり、アンカラ大学医学部での広範な教育と、Selcuk University Faculty of Medicineでの専門教育を受けています。Selcuk Universityの准教授として、後にCleveland Clinic Ohioの教授として、医師は尿路腫瘍学に焦点を当てました。専門分野には、男性不妊症とインポテンス、神経泌尿器学、マイクロ血管手術が含まれ、University of PittsburghとMercy Universityでの研修を受けています。

医師は国際的なインデックスに16の科学論文を、国内の雑誌に58の論文を発表し、様々な会議で47のコミュニケを行い、49の国際的な引用があります。医師は国内の泌尿器科およびアンドロロジー会議で、講演者およびセッションチェアマンとして積極的に参加しています。

Dr. Vladimir Yutkin Vladimir Yutkin is a highly experienced doctor at the Hadassah Medical Center, with over 20 years of experience. Key takeaways:

• Graduated from the Faculty of Medicine of the Hebrew University of Jerusalem (Israel) in 1996;
• Over 20 years of experience;
• Specialty is diagnosis and treatment of temporomandibular joint disorders;
• Speaks English, Hebrew, and Russian.

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Urologist, Specialist in Oncourology

Dr. Zohar Dotan is Head of the Urology Department at Sheba Medical Center. He is a leading uro-oncologist and a pioneer of robotic and laparoscopic urologic surgery in Israel.

He has authored more than 50 scientific publications. He is a regular speaker at international conferences. He has received awards from the American Association of Clinical Surgery, including recognition for research in prostate cancer treatment.

Leadership and credentials: Head of the Israeli Uro-Oncology Society. Assistant Professor at Tel Aviv University. Member of the Israeli, American, and European Urological Associations. Training: MD from Tel Aviv University and a PhD in Genetics. Urology residency at Sheba Medical Center. Fellowship in uro-oncology and laparoscopic surgery at Memorial Sloan Kettering, New York.

Radiotherapist

Tamar Jablonski-Perec is an oncologist at the Hadassah Medical Center who received her Doctor of Medical Sciences at the Hebrew University in Jerusalem and completed an internship at the renowned Sloan-Kettering Cancer Center in New York. Her key takeaways include:

• Head of Institute of Oncology in 1994
• Head of Breast Cancer Treatment Center in 1998
• Professor of the Department of Oncology at the Hebrew University in 2006
• Member of several international cancer communities
• Awarded a scholarship from the Hadassah Medical School

オファー・ナタン・ゴフリット教授は、泌尿器科医です。ハダッサ医療センター泌尿器科の主任医師です。米国シカゴ大学病院で侵襲的泌尿器科と腫瘍学のインターンシップを完了しました。ロボット手術を行う資格を取得しました。

ヘブライ大学で泌尿器科手術を教えています。膀胱と腎臓の腫瘍性疾患の研究を行っています。多数の科学論文や記事の著者です。泌尿器科への貢献で国内外のプロフェッショナルな賞を受けています。

専門分野：

• 男性および女性の泌尿生殖器系疾患の外科的治療;
• 膀胱と前立腺の癌治療;
• 泌尿器内視鏡手術;
• ダ・ヴィンチロボットを使用した手術 .

プロフェッサー ドクター エドゥアルド・ベヒトはドイツで41年の経験を持つ泌尿器科医であり、アテネのカポディアストリアス大学から名誉博士号を授与されています。彼の主なポイントは以下の通りです:

• "フランクフルト・アム・マイン eV インターディシプリナリー ユロオンコロジー" 協会の会長
• 1972年にマインツのヨハネス グーテンベルク大学を卒業
• 1980年に同大学の医療クリニック、腎臓病学科で博士号を取得
• 1994年からフランクフルト・アム・マインのゲーテ大学で講師を務める
• 泌尿器科腫瘍学、前立腺癌の低侵襲治療、臓器保存腎腫瘍手術、前立腺腺腫の治療、再建泌尿器科、尿道手術、小児泌尿器科、腎臓結石治療などの分野に注力
• 彼のクレジットに100以上の科学論文がある